Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call
Pacific Biosciences of California (NASDAQ: PACB) announced its quarterly conference call to discuss the second quarter 2021 financial results scheduled for August 3, 2021, at 4:30 pm ET.
Rhea-AI Summary
Pacific Biosciences of California (NASDAQ: PACB) announced its quarterly conference call to discuss the second quarter 2021 financial results scheduled for August 3, 2021, at 4:30 pm ET. The call will be accessible via webcast on the company's investor relations website. Pacific Biosciences focuses on providing scientists with long-read sequencing technology through its innovative instruments, enhancing research in genomics and epigenomics across various fields.
Positive
- Innovative long-read sequencing technology enhances research capabilities.
- Cited in thousands of peer-reviewed publications, indicating strong scientific engagement.
Negative
- None.
Details
News Market Reaction – PACB
The recorded move for PACB in the trading session of this news was +7.23%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time.
The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.
Date: Tuesday, August 3, 2021
Time: 4:30pm ET
Listen via Internet: https://investor.pacificbiosciences.com/
Toll-free: 888.366.7247
International: 707.287.9330
Conference ID: 6914707
Replay: https://investor.pacificbiosciences.com
About Pacific Biosciences
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.
Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacificbiosciences.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.